Articles by Jorge Cortes, MD
The rate of response was “significantly higher” with asciminib compared with tyrosine kinase inhibitors.
Dr. Cortes chats about the “boom” in treatments for chronic myeloid leukemia (CML), and where he sees a need for balance.
The award was created in honor of Michael J. Keating, MD, a founding member and past president of SOHO.
Dr. Cortes speaks about the plenary session he delivered during the Eleventh Annual Meeting of SOHO.
Dr. Cortes and colleagues presented the research during the 2023 American Society of Clinical Oncology Annual Meeting.
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.